Glycated Hemoglobin as A Marker for Predicting Outcomes of Patients with Hemorrhagic Stroke
DOI:
https://doi.org/10.70749/ijbr.v3i7.1799Keywords:
Hemorrhagic Stroke, Glycated Hemoglobin (HbA1c), Outcomes, Diabetes Mellitus, Neurological RecoveryAbstract
Background: A severe cerebrovascular event with a high morbidity and fatality rate is hemorrhagic stroke (HS). Finding trustworthy prognostic indicators is essential to enhancing clinical results. Glycated hemoglobin (HbA1c), which has been connected to vascular dysfunction and the risk of stroke, is a measure of long-term glycemic management. Its predictive usefulness for hemorrhagic stroke outcomes is still unknown, though. Objective: This study aims to evaluate the role of HbA1c as a predictive biomarker for clinical outcomes in patients with hemorrhagic stroke, focusing on stroke severity, functional recovery, and mortality. Methods: At Quetta's Bolan Medical Complex Hospital, 300 patients with hemorrhagic stroke were the subjects of a prospective observational study. Based on their HbA1c readings, patients were divided into three groups: <5.7%, 5.7%–6.4%, and >6.5%. The Glasgow Coma Scale (GCS) and NIH Stroke Scale (NIHSS) were used to measure clinical severity. The modified Rankin Scale (mRS) was used to assess functional outcomes both at discharge and ninety days after the stroke. Independent predictors of unfavorable outcomes were found using logistic regression analysis. Results: Significantly negative outcomes were seen by patients with HbA1c >6.5%, including higher mean blood pressure (160/95 mmHg ± 14, p=0.001), higher NIHSS scores (14.7 ± 5.2, p=0.002), and lower GCS scores (8.9 ± 3.2, p=0.001). This group had the lowest functional independence (18.2%, p=0.001) and the highest mortality (36.4%, p=0.002). Along with age >60 years, hypertension, and high NIHSS scores, logistic regression verified that HbA1c >6.5% was an independent predictor of poor functional recovery (OR: 2.9, p=0.001). Conclusion: In hemorrhagic stroke patients, elevated HbA1c levels are linked to worse functional recovery, higher mortality, and more severe stroke. A major independent predictor of unfavorable outcomes is a HbA1c >6.5%. These results imply that regular HbA1c testing could help patients with hemorrhagic stroke with risk assessment and clinical decision-making.
Downloads
References
1. Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017). IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Research and Clinical Practice, 128, 40–50.
https://doi.org/10.1016/j.diabres.2017.03.024
2. Roglic G. (2016). World Health Organization eds. Global report on diabetes. Geneva, Switzerland: World Health Organization.
3. Tun, N. N., Arunagirinathan, G., Munshi, S. K., & Pappachan, J. M. (2017). Diabetes mellitus and stroke: A clinical update. World Journal of Diabetes, 8(6), 235.
https://doi.org/10.4239/wjd.v8.i6.235
4. Beckman, J. A., Paneni, F., Cosentino, F., & Creager, M. A. (2013). Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: part II. European Heart Journal, 34(31), 2444-2452.
https://doi.org/10.1093/eurheartj/eht142
5. Lau, L., Lew, J., Borschmann, K., Thijs, V., & Ekinci, E. I. (2018). Prevalence of diabetes and its effects on stroke outcomes: A meta‐analysis and literature review. Journal of Diabetes Investigation, 10(3), 780-792.
https://doi.org/10.1111/jdi.12932
6. O'Donnell, M. J., Chin, S. L., Rangarajan, S., Xavier, D., Liu, L., Zhang, H., Rao-Melacini, P., Zhang, X., Pais, P., Agapay, S., Lopez-Jaramillo, P., Damasceno, A., Langhorne, P., McQueen, M. J., Rosengren, A., Dehghan, M., Hankey, G. J., Dans, A. L., Elsayed, A., … Yusuf, S. (2016). Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. The Lancet, 388(10046), 761-775.
https://doi.org/10.1016/s0140-6736(16)30506-2
7. Eriksson, M., Carlberg, B., & Eliasson, M. (2012). The disparity in long-term survival after a first stroke in patients with and without diabetes persists: The northern Sweden MONICA study. Cerebrovascular Diseases, 34(2), 153-160.
https://doi.org/10.1159/000339763
8. Piernik-Yoder, B., & Ketchum, N. (2013). Rehabilitation outcomes of stroke patients with and without diabetes. Archives of Physical Medicine and Rehabilitation, 94(8), 1508-1512.
https://doi.org/10.1016/j.apmr.2013.04.014
9. Li, H., Yang, M., & Chung, K. (2011). Predictors for readmission of acute ischemic stroke in Taiwan. Journal of the Formosan Medical Association, 110(10), 627-633.
https://doi.org/10.1016/j.jfma.2011.08.004
10. Papazafiropoulou, A., Tentolouris, N., Bousboulas, S., Sotiropoulos, A., Tamvakos, E., Peppas, T., Kardara, M., & Pappas, S. (2010). In-hospital mortality in a tertiary referral hospital: Causes of death and comparison between patients with and without diabetes. Experimental and Clinical Endocrinology & Diabetes, 118(05), 315-319.
https://doi.org/10.1055/s-0029-1241215
11. Ripley, D. L., Seel, R. T., Macciocchi, S. N., Schara, S. L., Raziano, K., & Ericksen, J. J. (2007). The impact of diabetes mellitus on stroke acute rehabilitation outcomes. American Journal of Physical Medicine & Rehabilitation, 86(9), 754-761.
https://doi.org/10.1097/phm.0b013e31813e0769
12. Tuttolomondo, A., Pinto, A., Salemi, G., Di Raimondo, D., Di Sciacca, R., Fernandez, P., Ragonese, P., Savettieri, G., & Licata, G. (2008). Diabetic and non-diabetic subjects with ischemic stroke: Differences, subtype distribution and outcome. Nutrition, Metabolism and Cardiovascular Diseases, 18(2), 152-157.
https://doi.org/10.1016/j.numecd.2007.02.003
13. D'Emden, M. C., Shaw, J. E., Colman, P. G., Colagiuri, S., Twigg, S. M., Jones, G. R., Goodall, I., Schneider, H. G., & Cheung, N. W. (2012). The role of HbA1c in the diagnosis of diabetes mellitus in Australia. Medical Journal of Australia, 197(4), 220-221.
https://doi.org/10.5694/mja12.10988
14. Mackey, P. A., & Whitaker, M. D. (2015). Diabetes mellitus and hyperglycemia management in the hospitalized patient. The Journal for Nurse Practitioners, 11(5), 531-537.
https://doi.org/10.1016/j.nurpra.2015.02.016
15. Khan, H. A., Sobki, S. H., & Khan, S. A. (2007). Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia. Clinical and Experimental Medicine, 7(1), 24-29.
https://doi.org/10.1007/s10238-007-0121-3
16. Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A., & Sakharkar, M. K. (2016). Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker Insights, 11, BMI.S38440.
https://doi.org/10.4137/bmi.s38440
17. Kranenburg, G., Van der Graaf, Y., Van der Leeuw, J., Nathoe, H. M., De Borst, G. J., Kappelle, L. J., Visseren, F. L., & Westerink, J. (2015). The relation between HbA1c and cardiovascular events in patients with type 2 diabetes with and without vascular disease. Diabetes Care, 38(10), 1930-1936.
https://doi.org/10.2337/dc15-0493
18. Wang, J., Li, Q., & Liu, J. (2020). Prognostic factors in spontaneous intracerebral hemorrhage: A systematic review. World Neurosurgery, 140, e67–e77. https://doi.org/10.1016/j.wneu.2020.04.063
19. American Diabetes Association. (2022). Diagnosis and classification of diabetes mellitus. Diabetes Care, 45(Suppl 1), S17–S38.
https://doi.org/10.2337/dc22-S002
20. Kim, Y. H., Her, A., Jeong, M. H., Kim, B., Hong, S., Kim, S., Ahn, C., Kim, J., Ko, Y., Choi, D., Hong, M., & Jang, Y. (2020). Effect of renin-angiotensin system inhibitors on major clinical outcomes in patients with acute myocardial infarction and prediabetes or diabetes after successful implantation of newer-generation drug-eluting stents. Journal of Diabetes and its Complications, 34(6), 107574.
https://doi.org/10.1016/j.jdiacomp.2020.107574
21. Zhang, X., Yang, Y., & Lin, Y. (2021). Glycemic variability and hemorrhagic stroke prognosis: A prospective study. Journal of Stroke, 23(3), 419–428.
https://doi.org/10.5853/jos.2021.00999
22. Zhang, G., He, M., Xu, Y., Li, X., Cai, Z., Guo, Z., Meng, P., Ji, N., He, X., & Pang, L. (2018). Hemoglobin A1c predicts hemorrhagic transformation and poor outcomes after acute anterior stroke. European Journal of Neurology, 25(12), 1432.
https://doi.org/10.1111/ene.13747
23. Kang, K., Lu, J., Ju, Y., Wang, W., Shen, Y., Wang, A., Cao, Z., & Zhao, X. (2019). Association of pre- and post-stroke glycemic status with clinical outcome in spontaneous intracerebral hemorrhage. Scientific Reports, 9(1).
https://doi.org/10.1038/s41598-019-55610-z
24. Jafar, N., Braksick, S. A., Rabinstein, A. A., & Rabinstein, A. A. (2021). Glycated Hemoglobin as a Marker for Predicting Outcomes of Patients With Stroke (Ischemic and Hemorrhagic): A Systematic Review and Meta-Analysis. Frontiers in Neurology, 12, 666919.
https://doi.org/10.3389/fneur.2021.666919
25. Sung, J. Y., Chen, C. I., Hsieh, Y. C., Chen, Y. R., Wu, H. C., Chan, L., Hu, C. J., Hu, H. H., Chiou, H. Y., & Chi, N. F. (2017). Comparison of admission random glucose, fasting glucose, and glycated hemoglobin in predicting the neurological outcome of acute ischemic stroke: a retrospective study. PeerJ, 5, e2948–e2948.
https://doi.org/10.7717/peerj.2948
26. Sunaga, K., Miura, K., Naruse, Y., Sakurai, M., Morikawa, Y., Kurosawa, Y., & Nakagawa, H. (2008). Glycated hemoglobin and risk of stroke, ischemic and hemorrhagic, in Japanese men and women. Cerebrovascular Diseases, 26(3), 310-316.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
